<DOC>
	<DOCNO>NCT00363324</DOCNO>
	<brief_summary>This study aim assess effect bone marrow cell arrhythmia risk variable patient acute myocardial infarction .</brief_summary>
	<brief_title>Bone Marrow Cells Myocardial Infarction</brief_title>
	<detailed_description>This randomize , double-blinded study , patient treat thrombolytic therapy acute myocardial infarction randomize receive bone-marrow derive stem cell sham-infusion time percutaneous coronary intervention target vessel . The end-points many arrhythmia risk variable , suchs heart rate variability , T-wave alternans many ECG variable well systolic diastolic leave ventricular function .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Acute STelevation myocardial infarction treat thrombolytic therapy Indication rescue PCI , severe clinical heart failure , age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>stem cell</keyword>
	<keyword>acute myocardial infarction</keyword>
</DOC>